LFCR LIFECORE BIOMEDICAL, INC. \DE\


$ 6.41 $ -0.06 (-0.93 %)    

Tuesday, 14-Oct-2025 12:11:53 EDT
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
$ 6.56
$ 6.39 x 233
$ 6.42 x 101
$ 6.34 - $ 6.56
$ 4.51 - $ 8.85
128,283
na
247.27M
$ 0.88
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 keybanc-initiates-coverage-on-lifecore-biomedical-with-sector-weight-rating

Keybanc analyst Paul Knight initiates coverage on Lifecore Biomedical (NASDAQ:LFCR) with a Sector Weight rating.

 lifecore-biomedical-sees-fy2026-sales-74000m-76000m-vs-127802m-est

Lifecore Biomedical (NASDAQ:LFCR) sees FY2026 sales of $74.000 million-$76.000 million vs $127.802 million analyst estimate.

 lifecore-biomedical-q4-eps-006-beats-010-estimate-sales-36444m-beat-35363m-estimate

Lifecore Biomedical (NASDAQ:LFCR) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $...

 lifecore-signs-10-year-deal-to-make-eye-drug-boosting-long-term-revenue-growth-prospects

Lifecore Biomedical, Inc. (NASDAQ:LFCR) ("Lifecore"), a fully integrated contract development and manufacturing organiz...

 william-blair-initiates-coverage-on-lifecore-biomedical-with-outperform-rating

William Blair analyst Max Smock initiates coverage on Lifecore Biomedical (NASDAQ:LFCR) with a Outperform rating.

 lifecore-biomedical-q3-2025-gaap-eps-047-misses-015-estimate-sales-35154m-beat-33229m-estimate

Lifecore Biomedical (NASDAQ:LFCR) reported quarterly losses of $(0.47) per share which missed the analyst consensus estimate of...

 lifecore-biomedical-announces-17m-sales-agreement-for-10-head-isolator-filler-receives-7m-at-closing-expects-remaining-payments-in-3-tranches-over-18-months

Company Believes it is Well Positioned for Mid-Term and Long-Term Growth asCurrent Capacity Continues to Support up to $300 Mil...

 stephens--co-reiterates-equal-weight-on-lifecore-biomedical-maintains-6-price-target

Stephens & Co. analyst Jacob Johnson reiterates Lifecore Biomedical (NASDAQ:LFCR) with a Equal-Weight and maintains $6 p...

 us-stocks-poised-to-open-higher-as-futures-advance-tesla-bumble-lifecore-bio-in-focus

U.S. stock futures were higher on Friday, the slipping in first trading session of 2025. All four index futures advanced in pre...

 resources-connection-sps-commerce-and-3-stocks-to-watch-heading-into-friday

US stock futures up, GeneDx appoints new COO, Lifecore beats expectations, SPS Commerce acquires Carbon6, Resources Connection ...

 lifecore-biomedical-q2-2025-gaap-eps-025-beats-029-estimate-sales-3260m-beat-2975m-estimate

Lifecore Biomedical (NASDAQ:LFCR) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION